$BRT Cashflow Statement | Understand Stock

$BRT

$12.94 -$0.30 (2.27%) Close

$BRT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Provision for credit loss
Amortization of deferred financing fees
Amortization of debt fair value adjustment
Amortization of deferred loan fee income
Amortization of restricted stock and restricted stock units
Equity in loss (earnings) of unconsolidated joint ventures
Equity in earnings on sale of real estate of unconsolidated ventures
Impairment charge
Gain on sale of real estate
Gain on sale of partnership interest
Gain on insurance recovery
Loss on extinguishment of debt

Increases and decreases from changes in other assets and liabilities:
Decrease (increase) in other assets
Increase in accounts payable and accrued liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Collections from real estate loans
Proceeds from the sale of mortgage loan
Improvements to real estate owned
Purchase and consolidation of joint venture properties
Additions to loan receivables
Proceeds from the sale of real estate owned
Proceeds from the sale of joint venture interests
Distributions from unconsolidated joint ventures
Contributions to unconsolidated joint ventures
Proceeds from insurance recoveries
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from mortgages payable
Mortgage payoffs
Mortgage principal payments
Proceeds from credit facility
Repayment of credit facility
Increase in deferred financing costs
Dividends paid
Distributions to non-controlling interests
Proceeds from the sale of common stock
Proceeds from the issuance of DRP shares
Repurchase of shares of common stock
Net cash (used in) provided by financing activities
Net (decrease) increase in cash, cash equivalents, restricted cash and escrows:
Cash, cash equivalents, restricted cash and escrows at beginning of year
Cash, cash equivalents, restricted cash and escrows at end of year
Supplemental disclosures of cash flow information:
Cash paid during the year for interest expense
Cash paid (net of refunds received) during the year for income and excise taxes
Increase in real estate assets
Increase in other assets
Increase in mortgage payable
Increase in deferred loan costs
Increase in accounts payable and accrued liabilities
Decrease in investment in unconsolidated joint ventures
Purchase and consolidation of investment in joint venture
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash and cash equivalents
Restricted cash
Escrows (Other assets)

Comments